L-Aspartic acid dibenzyl ester tosylate

L-Aspartic acid dibenzyl ester tosylate is a protected amino acid derivative derived from L-aspartic acid, featuring the side-chain carboxyl group converted to a dibenzyl ester while the amino acid framework is maintained as a functional precursor for further transformations. The molecule contains an amino group and a carboxylate functionality masked as benzyl esters, and the "tosylate" component indicates an additional tosyl-protected leaving group or sulfonate-derived protection that can modulate chemoselectivity during stepwise synthesis. In peptide-related and synthetic chemistry contexts, this compound is employed as a protected aspartate building block to control reactivity of the carboxyl groups and to support preparation of aspartyl-containing intermediates, conjugates, and other structurally defined amino acid derivatives.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP00450

CAS No:2886-33-1

Synonyms/Alias:2886-33-1;h-asp(obzl)-obzltosoh;H-Asp(OBzl)-OBzl.TosOH;(s)-dibenzyl2-aminosuccinate4-methylbenzenesulfonate;l-asparticaciddibenzylestertosylate;SBB058098;L-Asparticaciddibenzylesterp-toluenesulfonatesalt;H-Asp(OBzl)-OBzl.Tos;L-Asparticaciddibenzylesterp-toluenesulfonate;H-Asp(OBzl)-OBzlinvertedexclamationmarkcurrencyTosOH;L-Asparticaciddibenzylester4-toluenesulfonate;diphenylmethyl(2S)-2-aminobutane-1,4-dioate,4-methylbenzenesulfonicacid;PubChem18995;Asp(OBzl)-OBzl?TosOH;H-Asp(OBzl)-OBzlosOH;AC1MDB4E;Maybridge1_003976;H-Asp(OBzl)-OBzl.Tos-OH;459887_ALDRICH;C25H27NO7S;SCHEMBL5396953;Jsp005508;CTK1A1883;HMS552M16;HLMUYZYLPUHSNV-NTISSMGPSA-N

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C25H27NO7S
M.W/Mr.
485.6

L-Aspartic acid dibenzyl ester tosylate is an L-aspartate-derived amino acid ester intermediate in which the amino acid backbone is converted to a dibenzyl ester and the side-chain functionality is present as a tosylate leaving group, enabling controlled downstream transformations. The molecule retains the stereogenic center of L-aspartic acid, and the benzyl ester groups provide acid-labile protection that is compatible with peptide-coupling workflows after deprotection. The tosylate on the side-chain oxygen introduces a robust, non-nucleophilic handle that can be displaced under nucleophilic substitution conditions to install diverse side-chain motifs. The combination of protected carboxylate ester groups and a reactive sulfonate leaving group supports both stereochemically defined intermediate construction and functionalized amino acid derivative synthesis for synthetic and biochemical research.

1. Protected Amino Acid Synthesis

L-Aspartic acid dibenzyl ester tosylate is used as a protected amino acid intermediate for building stereodefined aspartate derivatives in protected amino acid synthesis and peptide building block preparation. The dibenzyl ester functionality masks the α- and side-chain carboxylates during coupling chemistry, while the tosylate provides a controlled transformation point for side-chain modification without prematurely exposing polar acid groups. Side-chain functionalization via tosylate displacement can generate aspartate analogs bearing nucleophilic substituents suitable for subsequent ester hydrolysis, amide formation, or further protection/deprotection planning. L-Aspartic acid dibenzyl ester tosylate therefore supports stepwise synthesis of functionalized aspartate building blocks that feed into peptide coupling chemistry and downstream scaffold diversification.

2. Side-Chain Functionalization

L-Aspartic acid dibenzyl ester tosylate is applied in side-chain functionalization strategies where the tosylate leaving group enables installation of heteroatom-containing substituents onto the aspartate framework. The L-configuration preserves stereochemical integrity at the α-carbon, while the ester-protected carboxylates reduce competing side reactions during nucleophile introduction at the side-chain position. The sulfonate leaving group can be used to generate derivatives that carry protected alcohols, amines, or other nucleophile-derived substituents, which can then be converted into amide or ester linkages for incorporation into larger molecules. L-Aspartic acid dibenzyl ester tosylate thereby serves as a practical chiral intermediate for producing functionalized amino acid derivatives used in synthetic organic chemistry and peptide analog construction.

3. Peptide Coupling Chemistry

L-Aspartic acid dibenzyl ester tosylate is utilized in peptide synthesis planning where protected aspartate esters act as coupling-compatible building blocks after appropriate deprotection and activation steps. The dibenzyl ester groups provide a protecting-group platform that can be removed under hydrogenolysis-compatible conditions to reveal carboxylates for subsequent activation to activated esters or acid derivatives. The tosylate functionality can be retained for controlled timing of side-chain elaboration, allowing the synthesis route to separate side-chain modification from backbone coupling. L-Aspartic acid dibenzyl ester tosylate supports the preparation of aspartate-containing peptide fragments and peptidomimetic precursors, enabling stereochemically defined incorporation of modified side chains into peptide sequences.

4. Chemical Biology Probes

L-Aspartic acid dibenzyl ester tosylate is suitable for chemical biology research aimed at generating amino acid-based probes and labeling handles derived from aspartate side-chain chemistry. The tosylate group provides a reactive site for introducing nucleophile-derived functional groups that can later be adapted into conjugation-ready motifs, while the dibenzyl ester protection helps manage solubility and reactivity during intermediate synthesis. The L-aspartate stereocenter supports consistent spatial presentation of the side-chain substituent, which can be relevant for molecular recognition studies and structure-activity relationship investigations. L-Aspartic acid dibenzyl ester tosylate can therefore be employed to prepare derivatized amino acid scaffolds used in labeling chemistry and biochemical reagent construction.

5. Pharmaceutical Intermediate Preparation

L-Aspartic acid dibenzyl ester tosylate is applied as a chiral intermediate in pharmaceutical intermediate preparation where controlled functional group interconversion is required for route design. The protected ester groups allow handling under conditions that might otherwise cause premature acid-driven side reactions, and the tosylate provides a leaving group suitable for installing substituents that align with medicinal chemistry motifs. The stereodefined L-aspartate core supports downstream conversion into carboxylic acid or amide functionalities commonly encountered in drug-like structures and peptidomimetic candidates. L-Aspartic acid dibenzyl ester tosylate can be integrated into fine chemical synthesis workflows that produce aspartate-derived fragments for medicinal chemistry libraries and process chemistry intermediate generation.

6. Process Chemistry Intermediate

L-Aspartic acid dibenzyl ester tosylate is relevant to process chemistry intermediate development because it combines stable protecting-group behavior with a clear transformation handle on the side chain. The dibenzyl ester protection can be managed to maintain functional-group compatibility across multistep sequences, while the tosylate leaving group enables predictable substitution chemistry to access a range of aspartate-derived derivatives. The defined L-stereochemistry supports reproducible intermediate quality for downstream conversion into activated acids, amides, or peptide coupling partners. L-Aspartic acid dibenzyl ester tosylate therefore serves as a manufacturable chiral amino acid intermediate for specialty chemical production and industrial-scale fine chemical synthesis where functional group orchestration impacts overall route efficiency.

Abbr
H-Asp(OBzl)-OBzl.TOS
InChI
1S/C18H19NO4.C7H8O3S/c19-16(18(21)23-13-15-9-5-2-6-10-15)11-17(20)22-12-14-7-3-1-4-8-14;1-6-2-4-7(5-3-6)11(8,9)10/h1-10,16H,11-13,19H2;2-5H,1H3,(H,8,9,10)/t16-;/m0./s1
InChI Key
HLMUYZYLPUHSNV-NTISSMGPSA-N
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.C1=CC=C(C=C1)COC(=O)CC(C(=O)OCC2=CC=CC=C2)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide CDMOPeptide Analysis ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers